MCID: EXN002
MIFTS: 57

Exanthem

Categories: Skin diseases, Infectious diseases

Aliases & Classifications for Exanthem

Summaries for Exanthem

MedlinePlus : 41 a rash is an area of irritated or swollen skin. many rashes are itchy, red, painful, and irritated. some rashes can also lead to blisters or patches of raw skin. rashes are a symptom of many different medical problems. other causes include irritating substances and allergies. certain genes can make people more likely to get rashes. contact dermatitis is a common type of rash. it causes redness, itching, and sometimes small bumps. you get the rash where you have touched an irritant, such as a chemical, or something you are allergic to, like poison ivy. some rashes develop right away. others form over several days. although most rashes clear up fairly quickly, others are long-lasting and need long-term treatment. because rashes can be caused by many different things, it's important to figure out what kind you have before you treat it. if it is a bad rash, if it does not go away, or if you have other symptoms, you should see your health care provider. treatments may include moisturizers, lotions, baths, cortisone creams that relieve swelling, and antihistamines, which relieve itching.

MalaCards based summary : Exanthem, also known as exanthema, is related to chickenpox and occupational dermatitis. An important gene associated with Exanthem is CD40LG (CD40 Ligand), and among its related pathways/superpathways are ERK Signaling and PEDF Induced Signaling. The drugs Apraclonidine and Gabapentin have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and breast, and related phenotypes are Decreased viability and homeostasis/metabolism

Wikipedia : 72 An exanthem or exanthema (from Greek ἐξάνθημα exánthēma, \"a breaking out\") is a widespread rash... more...

Related Diseases for Exanthem

Diseases in the Exanthem family:

Bacterial Exanthem Viral Exanthem

Diseases related to Exanthem via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 341)
id Related Disease Score Top Affiliating Genes
1 chickenpox 29.2 CD40LG CD79A CRP TNF TNFRSF1B
2 occupational dermatitis 28.7 EGFR ERBB2 HRAS KRAS MAP2K7
3 exanthema subitum 12.2
4 viral exanthem 12.0
5 bacterial exanthem 11.8
6 hand, foot and mouth disease 11.2
7 alcoholic neuropathy 11.0 CD40LG CD79A
8 calloso-genital dysplasia 11.0 CD40LG CD79A
9 variola major 10.9 CD40LG CD79A
10 mu chain disease 10.9 CD40LG CD79A
11 rabies 10.9 CD40LG CD79A
12 familial retinoblastoma 10.9 CD40LG CD79A
13 anti-basement membrane glomerulonephritis 10.9 CD40LG CD79A
14 microinvasive cervical squamous cell carcinoma 10.9 CD40LG CD79A
15 infiltrating ureter transitional cell carcinoma 10.9 EGFR ERBB2
16 fetal erythroblastosis 10.9 CD40LG CD79A
17 spinal canal and spinal cord meningioma 10.9 CD40LG CD79A
18 trichostrongyloidiasis 10.9 CD40LG CD79A
19 contagious pustular dermatitis 10.9
20 malignant skin fibrous histiocytoma 10.8 HRAS KRAS
21 leukodystrophy 10.8 CD40LG CD79A
22 hypersensitivity syndrome, carbamazepine-induced 10.8
23 retinal microaneurysm 10.8 CD40LG CD79A
24 heart septal defect 10.8 CD40LG CD79A
25 cryptorchidism arachnodactyly mental retardation 10.8 CD40LG CD79A
26 milk allergy 10.8 CD40LG IL1RN NLRP3
27 senile atrophy of choroid 10.8 CD79A TRIM21
28 oculo-cerebral dysplasia 10.8 CD40LG CD79A TLR9
29 angiomyoma 10.8 CD40LG CD79A NLRP3
30 autoimmune disease of cardiovascular system 10.7 CD40LG CD79A TLR9
31 leiomyosarcoma 10.7 CD40LG CD79A CRP
32 pancreatic vasoactive intestinal peptide producing tumor 10.7 CD40LG CD79A CRP
33 chronic mucocutaneous candidiasis 10.7 CD40LG CD79A CRP
34 malignant melanocytic peripheral nerve sheath tumor of mediastinum 10.7 CD40LG CD79A TLR9
35 partial circumpapillary choroid dystrophy 10.7 CD40LG CD79A CRP
36 brain germinoma 10.7 CD40LG CD79A TLR9
37 acute kidney tubular necrosis 10.7 CD40LG CD79A
38 breast adenoid cystic carcinoma 10.7 EGFR HRAS KRAS
39 spindle epithelial tumor with thymus-like differentiation tumor 10.7 EGFR HRAS KRAS
40 glycogen storage disease viii 10.7 CD40LG CD79A CRP
41 secretory meningioma 10.7 CD40LG CD79A
42 rheumatic heart disease 10.7 CD40LG CD79A CRP
43 hodgkin's lymphoma, nodular sclerosis 10.7 CD40LG CD79A
44 spastic entropion 10.7 CD40LG CD79A CRP
45 imperforate oropharynx-costo vetebral anomalies 10.7 CD40LG CD79A
46 pediatric supratentorial ependymoma 10.7 CD40LG CRP TLR9
47 inclusion conjunctivitis 10.7 CD79A IL1RN TNFRSF1B
48 thrombophlebitis migrans 10.7 CD40LG CD79A TNFRSF1B
49 sohval soffer syndrome 10.6 EGFR ERBB2 KRAS
50 olfactory neuroblastoma 10.6 EGFR HRAS KRAS

Graphical network of the top 20 diseases related to Exanthem:



Diseases related to Exanthem

Symptoms & Phenotypes for Exanthem

GenomeRNAi Phenotypes related to Exanthem according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00055-A-2 10.6 MTOR HRAS EGFR KALRN KRAS
2 Decreased viability GR00106-A-0 10.6 KRAS
3 Decreased viability GR00221-A-1 10.6 MTOR EGFR HRAS KALRN KRAS MAP2K7
4 Decreased viability GR00221-A-2 10.6 HRAS KALRN KRAS
5 Decreased viability GR00221-A-3 10.6 HRAS
6 Decreased viability GR00221-A-4 10.6 MTOR EGFR KALRN
7 Decreased viability GR00301-A 10.6 KALRN KRAS
8 Decreased viability GR00342-S-1 10.6 MAP2K7 MTOR KALRN
9 Decreased viability GR00342-S-2 10.6 MTOR KALRN
10 Decreased viability GR00342-S-3 10.6 KALRN
11 Decreased viability GR00381-A-1 10.6 KALRN KRAS
12 Decreased focal adhesion (FA) area, decreased FA length, decreased FA mean intensity, increased number of small and round FAs, increased FA abundance GR00210-A 9.8 MTOR EGFR ERBB2 HRAS HSPG2 KALRN
13 Decreased cell migration GR00055-A-1 9.77 EGFR HRAS KALRN KRAS MTOR
14 Decreased viability with paclitaxel GR00179-A-1 9.7 EGFR ERBB2 MTOR
15 Decreased viability with paclitaxel GR00179-A-2 9.7 MTOR
16 Decreased viability with paclitaxel GR00179-A-3 9.7 MTOR EGFR
17 Decreased substrate adherent cell growth GR00193-A-2 9.65 EGFR KALRN MAP2K7 MTOR
18 Decreased substrate adherent cell growth GR00193-A-3 9.65 MAP2K7
19 Increased transferrin (TF) endocytosis GR00363-A 9.4 CD40LG CD79A CRP EGFR ERBB2 HRAS

MGI Mouse Phenotypes related to Exanthem:

44 (show all 23)
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.53 ERBB2 HRAS HSPG2 IL1RN IL2 IL6
2 cellular MP:0005384 10.47 CD40LG CD79A EGFR ERBB2 HSPG2 IL1RN
3 cardiovascular system MP:0005385 10.45 MTOR TNF TNFRSF1B CD40LG CRP EGFR
4 hematopoietic system MP:0005397 10.43 IL6 KRAS MAP2K7 MTOR NLRP3 TLR9
5 mortality/aging MP:0010768 10.42 CD40LG EGFR ERBB2 HRAS HSPG2 IL1RN
6 immune system MP:0005387 10.41 CD40LG CD79A CRP EGFR HSPG2 IL1RN
7 growth/size/body region MP:0005378 10.38 ERBB2 HRAS HSPG2 IL1RN IL2 IL6
8 integument MP:0010771 10.37 TRIM21 CD40LG EGFR ERBB2 HRAS HSPG2
9 behavior/neurological MP:0005386 10.35 ERBB2 HRAS HSPG2 IL2 IL6 KALRN
10 endocrine/exocrine gland MP:0005379 10.35 IL6 KALRN KRAS MAP2K7 MTOR TNF
11 digestive/alimentary MP:0005381 10.28 EGFR ERBB2 HSPG2 IL2 IL6 KRAS
12 nervous system MP:0003631 10.28 ERBB2 HRAS HSPG2 IL6 KALRN KRAS
13 liver/biliary system MP:0005370 10.16 CD79A EGFR HSPG2 IL2 IL6 KRAS
14 neoplasm MP:0002006 10.16 CD79A EGFR ERBB2 HRAS IL2 IL6
15 craniofacial MP:0005382 10.14 EGFR ERBB2 HRAS HSPG2 KRAS TNF
16 muscle MP:0005369 10.13 EGFR ERBB2 HSPG2 IL6 KALRN KRAS
17 renal/urinary system MP:0005367 10.06 CD40LG CD79A EGFR HRAS IL6 KRAS
18 normal MP:0002873 10.02 NLRP3 CD79A EGFR ERBB2 HRAS KALRN
19 no phenotypic analysis MP:0003012 10.01 CD79A EGFR HRAS IL2 KALRN KRAS
20 reproductive system MP:0005389 10 EGFR ERBB2 IL1RN IL2 IL6 KALRN
21 respiratory system MP:0005388 9.85 EGFR ERBB2 HRAS HSPG2 IL2 IL6
22 skeleton MP:0005390 9.73 CD40LG EGFR ERBB2 HRAS HSPG2 IL1RN
23 vision/eye MP:0005391 9.23 EGFR HSPG2 IL2 IL6 KRAS MAP2K7

Drugs & Therapeutics for Exanthem

Drugs for Exanthem (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 930)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Apraclonidine Approved Phase 4,Phase 3 66711-21-5 2216
2
Gabapentin Approved, Investigational Phase 4,Phase 2 60142-96-3 3446
3
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
4
Latanoprost Approved, Investigational Phase 4 130209-82-4 5282380 5311221
5
Benzoyl peroxide Approved Phase 4,Phase 3,Phase 1,Phase 2 94-36-0 7187
6
Clindamycin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 18323-44-9 29029
7
Cetuximab Approved Phase 4,Phase 3,Phase 2,Phase 1 205923-56-4 56842117 2333
8
Nevirapine Approved Phase 4,Phase 3,Phase 2 129618-40-2 4463
9
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 53-03-2 5865
10 sodium fluoride Approved Phase 4,Phase 2 7681-49-4
11
Tacrolimus Approved, Investigational Phase 4,Phase 2,Phase 1 104987-11-3 445643 439492
12
Salicylic acid Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 69-72-7 338
13
Sorafenib Approved, Investigational Phase 4,Phase 2 284461-73-0 216239 406563
14
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 124-94-7 31307
15
Rifampin Approved Phase 4,Phase 1,Phase 2 13292-46-1 5458213 5381226
16
Sunitinib Approved, Investigational Phase 4,Phase 1 341031-54-7, 557795-19-4 5329102
17
Efavirenz Approved, Investigational Phase 4,Phase 3,Phase 1 154598-52-4 64139
18
Epinephrine Approved, Vet_approved Phase 4,Phase 2,Phase 3 51-43-4 5816
19
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 1 137-58-6 3676
20 Racepinephrine Approved Phase 4,Phase 2,Phase 3
21
Petrolatum Approved Phase 4,Phase 3,Phase 1,Phase 2 8009-03-8
22
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 564-25-0 54671203
23
Acetaminophen Approved Phase 4,Phase 3,Phase 1,Phase 2 103-90-2 1983
24
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-78-2 2244
25
Tazarotene Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 118292-40-3 5381
26
Azelaic acid Approved Phase 4,Phase 3,Phase 2,Phase 1 123-99-9 2266
27
Benzocaine Approved Phase 4,Phase 2,Phase 3,Early Phase 1 1994-09-7, 94-09-7 2337
28
Minocycline Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 10118-90-8 5281021
29
Betamethasone Approved, Vet_approved Phase 4,Phase 3,Phase 2 378-44-9 9782
30
Pimecrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 137071-32-0 6447131 17753757
31
Ephedrine Approved Phase 4,Phase 2 299-42-3 9294
32
Pseudoephedrine Approved Phase 4,Phase 2 90-82-4 7028
33
Menthol Approved Phase 4,Phase 3 2216-51-5 16666
34
Vancomycin Approved Phase 4,Phase 3 1404-90-6 441141 14969
35
Azithromycin Approved Phase 4,Phase 3,Phase 2,Early Phase 1 83905-01-5 55185 53477736 447043
36
Apremilast Approved, Investigational Phase 4,Phase 3,Phase 2 608141-41-9 11561674
37
Peginterferon alfa-2a Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 198153-51-4 5360545
38
Ribavirin Approved Phase 4,Phase 3,Phase 1 36791-04-5 37542
39
Zinc Approved Phase 4,Phase 3,Phase 1,Phase 2 7440-66-6 32051 23994
40
Zinc oxide Approved Phase 4,Phase 3 1314-13-2
41
Lamivudine Approved, Investigational Phase 4,Phase 2 134678-17-4 60825
42
Stavudine Approved, Investigational Phase 4 3056-17-5 18283
43
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 22916-47-8 4189
44
Everolimus Approved Phase 4,Phase 3,Phase 1,Phase 2 159351-69-6 6442177
45
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 2 128794-94-5 5281078
46
Mycophenolic acid Approved Phase 4,Phase 2 24280-93-1 446541
47
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 53123-88-9 5284616 6436030 46835353
48
Pentoxifylline Approved, Investigational Phase 4 6493-05-6 4740
49
Amifostine Approved, Investigational Phase 4 20537-88-6 2141
50
Verteporfin Approved, Investigational Phase 4 129497-78-5

Interventional clinical trials:

(show top 50) (show all 1791)

id Name Status NCT ID Phase Drugs
1 Elmex Gel Efficacy in Preventing White Spot Lesions Unknown status NCT00268138 Phase 4 elmex gel
2 Line Versus Spot Ablation in Persistent Atrial Fibrillation Unknown status NCT00196157 Phase 4
3 Micropulse Laser Trabeculoplasty Versus Selective Laser Trabeculoplasty for Treatment of Open Angle Glaucoma Unknown status NCT01956942 Phase 4
4 A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder Unknown status NCT00837343 Phase 4 quetiapine fumarate tablet (Seroquel)
5 Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission Unknown status NCT01901666 Phase 4 Growth Hormone
6 Effects of Gabapentin Enacarbil on Arousals, Heart Rate, Blood Pressure and PLMs in Restless Legs Syndrome Unknown status NCT02424695 Phase 4 Gabapentin Enacarbil (GEn);Placebo
7 The Laser in Pseudoexfoliation (LIP) Study Unknown status NCT01704989 Phase 4 Prostagladin
8 Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris Unknown status NCT01448733 Phase 4 Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning with with tretinoin 0.05% gel in the evening
9 A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne Unknown status NCT01422785 Phase 4 clindamycin phosphate 1.2%/tretinoin 0.025% gel alone;clindamycin phosphate 1.2%/tretinoin 0.025% gel plus benzoyl peroxide 6% foaming cloths
10 Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples) Unknown status NCT01260571 Phase 4 Benzoyl peroxide and sulfur
11 Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE) Unknown status NCT01553032 Phase 4 Erbitux®
12 Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash Completed NCT00219466 Phase 4
13 Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT Completed NCT00647205 Phase 4
14 Remineralisation of White Spot Lesions by Elmex® gelée in Post-orthodontic Patients Completed NCT01329731 Phase 4 elmex® gelée;negative control (placebo)
15 Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients Completed NCT02184299 Phase 4 Nevirapine;Prednisone
16 Therapeutic Effect of Two Fluoride Varnishes on White Spot Lesions: a Clinical Study Completed NCT00723515 Phase 4 sodium fluoride;sodium fluoride calcium fluoride
17 MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study Completed NCT02424097 Phase 4 CPP-ACP 5% sodium fluoride varnish & 900ppm fluoride paste;1,100pm F-toothpaste and 0.5%NaF rinse
18 Genotype Based Personalized Prescription of Nevirapine Completed NCT00986063 Phase 4
19 Caries-preventive Effect of a Dentifrice Containing 5,000 Ppm Fluoride in Orthodontic Patients Completed NCT01768390 Phase 4
20 Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots Completed NCT01149876 Phase 4 Tretinoin cream 0.05
21 Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants Completed NCT00702507 Phase 4 0.25 % Miconazole Nitrate Ointment
22 Selection of Immunosuppression in Kidney Transplant Recipients Depending on Pre-transplant Donor-specific T-cell Reactivity. Completed NCT01195194 Phase 4 PRE-TRANSPLANT (PRE=before)
23 Efficacy of Pentoxifylline on Chronic Kidney Disease Completed NCT00155246 Phase 4 pentoxifylline (drug)
24 Subcutaneous Amifostine Safety Study Completed NCT00158041 Phase 4 Amifostine administered subcutaneously
25 Comparison of the Effect of Fluoride Remineralizer Gel and Foam Completed NCT02490592 Phase 4
26 Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy Completed NCT01797861 Phase 4
27 SIGnificance of Routine Hysteroscopy Prior to a First 'in Vitro Fertilization'(IVF) Treatment Cycle Completed NCT01242852 Phase 4
28 A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster Completed NCT02152800 Phase 4 valacyclovir hydrocholoride
29 Bipolar Study in Adults at Least 18 Years of Age Completed NCT00067938 Phase 4 lamotrigine
30 Impact of Dihydroartemisinin-piperaquine Plus Primaquine on Malaria Transmission in Lampung Province, Sumatra Completed NCT01389557 Phase 4 Dihydroartemisinin-piperaquine with primaquine
31 A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nep Completed NCT00168857 Phase 4 telmisartan;losartan
32 FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra Completed NCT01656148 Phase 4 Fampridine-SR
33 Salicylic Acid Peels Combined With 4% Hydroquinone in the Treatment of Moderate to Severe Melasma in Hispanic Women Completed NCT00616239 Phase 4 20-30% Salicylic Acid peels to the right side of the face;20-30% Salicylic Acid peels to the left side of the face
34 Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients Completed NCT00882089 Phase 4
35 Oral Contraceptive Efficacy and Body Weight Completed NCT00662454 Phase 4 ethinyl estradiol / levonorgestrel;ethinyl estradiol / levonorgestrel
36 Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail Completed NCT02961998 Phase 4 Celecoxib;Sorafenib
37 Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®) Completed NCT00928577 Phase 4
38 A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Completed NCT02143882 Phase 4 Fluenz
39 Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia Completed NCT00232232 Phase 4 Fish oil
40 Prednisolone Pharmacokinetics in Severe Asthma Completed NCT00662298 Phase 4 prednisolone
41 NOW Thai HAART Study Completed NCT00367731 Phase 4 Highly Active Antiretroviral Treatment (combination of :NRTI, NNRTI,or PI)
42 Comparison of Efficacy of Intralesional Triamcinolone Injection and Clobetasol Propionate Ointment for Psoriatic Nails Completed NCT01703325 Phase 4 0.1% triamcinolone , 0.05% clobetasol propionate ointment
43 Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C:An Open-label Control Study in China Completed NCT02898922 Phase 4
44 Carotene and Retinol Efficacy Trial Completed NCT00712647 Phase 4 Beta Carotene and Retinol
45 CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial Completed NCT00847912 Phase 4 5-fluorouracil;Placebo, vehicle control
46 Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis Completed NCT00617643 Phase 4 Nevirapine without dose escalation;Nevirapine initiation with dose escalation
47 Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa Completed NCT01088516 Phase 4 Lopinavir/Ritonavir (200/50 mg) Tablets + Zidovudine + 3TC
48 Evaluation of an Herbal-Based De-Pigmenting System Completed NCT02138539 Phase 4 Hydroquinone
49 Treatment of Lower Extremity Spider Veins With Excel V Completed NCT01362192 Phase 4
50 Fractional CO2 Treatment of Acne Scars in Asians Completed NCT00748462 Phase 4

Search NIH Clinical Center for Exanthem

Cochrane evidence based reviews: exanthema

Genetic Tests for Exanthem

Anatomical Context for Exanthem

MalaCards organs/tissues related to Exanthem:

39
Skin, Testes, Breast, Lung, Kidney, Eye, Bone

Publications for Exanthem

Articles related to Exanthem:

(show top 50) (show all 255)
id Title Authors Year
1
IgA multiple myeloma in a patient with an IgG pemphigus foliaceus-like exanthem. ( 28856664 )
2017
2
Assessment of histopathological features of maculopapular viral exanthem and drug-induced exanthem. ( 28914958 )
2017
3
Can Unilateral Pityriasis Rosea be Considered a Form of Superimposed Lateralized Exanthem? ( 28764276 )
2017
4
Dengue-Fieber und die Differenzialdiagnosen zu Exanthem, Fieber und Kopfschmerzen nach Fernreise. ( 28140551 )
2017
5
Unilateral laterothoracic exanthem. ( 28754336 )
2017
6
Superimposed lateralized exanthem in a 30-year-old woman. ( 28893877 )
2017
7
Exanthem und Ekzem bei einem anderthalbjAohrigen Jungen. ( 28214315 )
2017
8
Eruptive hypomelanosis in a child, a new viral exanthem. ( 26728822 )
2016
9
Monitoring of human herpesviruses-6 and -7 DNA in saliva samples during the acute and convalescent phases of exanthem subitum. ( 27648817 )
2016
10
Coxsackievirus A6 Polymorphic Exanthem in Israeli Children. ( 26463513 )
2016
11
Pityriasis Rosea, Gianotti-Crosti Syndrome, Asymmetric Periflexural Exanthem, Papular-Purpuric Gloves and Socks Syndrome, Eruptive Pseudoangiomatosis, and Eruptive Hypomelanosis: Do Their Epidemiological Data Substantiate Infectious Etiologies? ( 27103975 )
2016
12
"Tache noire": diagnostic clue in a febrile exanthem. ( 28038854 )
2016
13
Stammbetontes Exanthem mit Allgemeinsymptomatik. ( 26972204 )
2016
14
Image Gallery: A case of unilateral laterothoracic exanthem. ( 27996140 )
2016
15
Anogenital allergic contact dermatitis caused by methylchloroisothiazolinone, methylisothiazolinone and topical clotrimazole with subsequent generalized exanthem triggered by oral fluconazole. ( 27040872 )
2016
16
A mini-epidemic of eruptive hypomelanosis in three children of the same family; the first piece of epidemiological evidence for an infectious cause of a novel paraviral exanthem. ( 27038439 )
2016
17
Exanthem subitum (human herpesvirus-6 reactivation) after autologous stem cell transplantation. ( 26918962 )
2016
18
Lateralized exanthem mimicking figurate inflammatory dermatosis of infancy after methimazole therapy. ( 27272160 )
2016
19
Urticarial exanthem associated with Capnocytophaga canimorsus bacteremia after a dog bite. ( 27051842 )
2016
20
Unilateral Exanthem. ( 26120168 )
2015
21
Febrile Exanthem with Hyperferritinemia. ( 26705442 )
2015
22
Unilateral Laterothoracic Exanthem. ( 26187001 )
2015
23
Purpuric exanthem caused by Ross River virus infection. ( 25551310 )
2015
24
Localized exanthem due to echovirus 9. ( 25919440 )
2015
25
Aminopenicillin-associated exanthem: lymphocyte transformation testing revisited. ( 25323308 )
2014
26
Superimposed lateralized exanthem of childhood: report of a case related to adenovirus infection. ( 24635078 )
2014
27
Eruptive hypomelanosis: a novel exanthem associated with viral symptoms in children. ( 25229328 )
2014
28
Vesiculobullous viral exanthem due to chikungunya in an infant. ( 25593800 )
2014
29
Unilateral laterothoracic or asymmetric periflexural exanthem: is time to change the name of the disease? ( 25267301 )
2014
30
Black heel (talon noir) associated with a viral exanthem. ( 24222298 )
2013
31
Gianotti-Crosti syndrome, pityriasis rosea, asymmetrical periflexural exanthem, unilateral mediothoracic exanthem, eruptive pseudoangiomatosis, and papular-purpuric gloves and socks syndrome: a brief review and arguments for diagnostic criteria. ( 24470919 )
2012
32
Unilateral laterothoracic exanthem. ( 21989468 )
2012
33
Generalized purpuric drug exanthem with hemorrhagic plaques following bendamustine chemotherapy in a patient with B-prolymphocytic leukemia. ( 22290027 )
2012
34
Acetaminophen-induced exanthem of the breasts. ( 22838093 )
2012
35
Febrile illness with papular and vesicular exanthem and ulceronecrotic plaques. ( 23106676 )
2012
36
Histopathology of measles exanthem: a case with characteristic features and eosinophils. ( 22725635 )
2012
37
Drug-induced exanthem following dabigatran. ( 21881034 )
2011
38
A challenging case: Symmetrical drug related intertriginous and flexural exanthem, fixed drug eruption, or both? ( 22082466 )
2011
39
Asymmetrical periflexural exanthem of childhood with concurrence of molluscum contagiosum infection. ( 21457157 )
2011
40
Image in medicine. An exanthem with an annular pattern in a 2-year-old girl. Atypical viral exanthem with an annular pattern. ( 20838712 )
2010
41
Transient linear eruption: asymmetric periflexural exanthem or blaschkitis. ( 20609153 )
2010
42
Exanthem with cryopyrin associated periodic syndromes and consideration of IL-1 targeted therapy for neutrophilic predominant urticaria. ( 20657165 )
2010
43
Papular exanthem discloses acute myeloid leukaemia: interphase fluorescence in situ hybridization revealed deletion of p53 and gain at 8q22/8q24/Tel8q without trisomy 8. ( 19438543 )
2010
44
Infectious exanthem. ( 19375548 )
2009
45
Morbilliform exanthem induced by imiquimod in a patient with drug-related immunosuppression. ( 19196306 )
2009
46
Asymmetrical periflexural exanthem exhibiting pseudoisomorphic KAPebner response in an adult. ( 19094120 )
2009
47
Unilateral laterothoracic exanthem and primary Epstein-Barr virus infection: case report. ( 19483526 )
2009
48
An update on pityriasis rosea and other similar childhood exanthems. ( 19502983 )
2009
49
Symmetrical drug-related intertriginous and flexural exanthem due to oral risperidone. ( 19419476 )
2009
50
Maculopapular exanthem from propolis: case report and review of systemic cutaneous and non-cutaneous reactions. ( 20059499 )
2009

Variations for Exanthem

Expression for Exanthem

Search GEO for disease gene expression data for Exanthem.

Pathways for Exanthem

Pathways related to Exanthem according to GeneCards Suite gene sharing:

(show top 50) (show all 99)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.93 CD40LG EGFR ERBB2 HRAS HSPG2 IL2
2
Show member pathways
13.7 CD40LG EGFR ERBB2 HRAS IL2 IL6
3
Show member pathways
13.61 EGFR ERBB2 HRAS IL2 IL6 KRAS
4
Show member pathways
13.54 CD40LG CD79A EGFR ERBB2 HRAS KRAS
5
Show member pathways
13.4 CD79A EGFR ERBB2 HRAS IL2 IL6
6
Show member pathways
13.35 EGFR ERBB2 HRAS IL2 IL6 KRAS
7
Show member pathways
13.34 CD40LG EGFR ERBB2 HRAS IL2 IL6
8
Show member pathways
13.3 CD40LG EGFR ERBB2 HRAS IL2 IL6
9
Show member pathways
13.21 CD79A EGFR ERBB2 HRAS IL2 KRAS
10
Show member pathways
13.17 CD40LG EGFR ERBB2 HRAS IL1RN IL2
11
Show member pathways
13.15 CD40LG CD79A CRP EGFR ERBB2 HRAS
12
Show member pathways
13.13 EGFR HRAS IL2 IL6 KRAS MTOR
13
Show member pathways
13.13 CD79A EGFR HRAS HSPG2 IL2 IL6
14
Show member pathways
12.97 HRAS IL6 KRAS MAP2K7 TNF TNFRSF1B
15
Show member pathways
12.96 CD79A EGFR HRAS KRAS TNF TNFRSF1B
16
Show member pathways
12.95 IL2 IL6 MAP2K7 TLR9 TNF
17
Show member pathways
12.95 EGFR ERBB2 HRAS IL6 KRAS MAP2K7
18
Show member pathways
12.89 IL2 IL6 MAP2K7 NLRP3 TLR9 TNF
19
Show member pathways
12.89 EGFR HRAS IL1RN IL6 KRAS MAP2K7
20
Show member pathways
12.87 ERBB2 HRAS KRAS MAP2K7 MTOR
21
Show member pathways
12.84 EGFR HRAS KRAS MAP2K7 MTOR
22
Show member pathways
12.84 HRAS IL2 IL6 KRAS MTOR TNF
23
Show member pathways
12.81 CD79A EGFR ERBB2 HRAS KRAS MTOR
24 12.79 EGFR HRAS KRAS MAP2K7 TNF
25 12.77 EGFR HRAS IL2 IL6 KRAS MTOR
26 12.77 EGFR ERBB2 HRAS IL6 KRAS MTOR
27
Show member pathways
12.75 CD40LG EGFR IL2 IL6 TLR9 TNF
28
Show member pathways
12.71 CD40LG HRAS MAP2K7 TLR9 TNF TNFRSF1B
29
Show member pathways
12.71 CD40LG EGFR HRAS KRAS MAP2K7 TNF
30
Show member pathways
12.69 CD40LG CD79A HRAS IL2 MAP2K7 TNF
31
Show member pathways
12.68 CD79A HRAS KRAS MAP2K7 TNF
32
Show member pathways
12.65 EGFR ERBB2 HRAS IL6 KRAS MAP2K7
33
Show member pathways
12.63 EGFR ERBB2 HRAS IL2 IL6 KRAS
34 12.62 EGFR ERBB2 HRAS KRAS MTOR
35
Show member pathways
12.58 ERBB2 HRAS IL1RN KRAS MTOR
36
Show member pathways
12.57 EGFR ERBB2 HRAS KRAS MAP2K7 MTOR
37 12.55 CD40LG CD79A IL1RN IL2 TLR9 TNF
38 12.52 HRAS IL2 IL6 KRAS TNF
39
Show member pathways
12.51 EGFR ERBB2 HRAS KRAS MTOR TNF
40
Show member pathways
12.5 EGFR ERBB2 HRAS IL2 KRAS MTOR
41
Show member pathways
12.42 HRAS HSPG2 KRAS MTOR
42
Show member pathways
12.37 EGFR ERBB2 HRAS KRAS
43
Show member pathways
12.37 EGFR ERBB2 HRAS KRAS MAP2K7 MTOR
44
Show member pathways
12.35 EGFR ERBB2 HRAS KRAS MTOR
45
Show member pathways
12.32 CD40LG HRAS IL2 IL6 KRAS MAP2K7
46
Show member pathways
12.31 EGFR HRAS KRAS MAP2K7
47
Show member pathways
12.31 HRAS KRAS MAP2K7 MTOR
48
Show member pathways
12.3 HRAS IL2 IL6 MTOR
49 12.28 EGFR IL6 KRAS TLR9 TNF
50 12.27 EGFR ERBB2 HRAS KRAS MTOR

GO Terms for Exanthem

Cellular components related to Exanthem according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.81 CD40LG CRP EGFR HSPG2 IL1RN IL2
2 extracellular region GO:0005576 9.36 CD40LG CRP